The FREEDOM (Future Revascularization Evaluation in Patients With Diabetes Mellitus-Optimal Management of Multivessel Disease) trial will compare CABG and DES in patients with diabetes.
A study comparing the outcomes of all patients in New York state treated with CABG or percutaneous coronary intervention (PCI) demonstrated CABG was superior to PCI with DES in multivessel (more than one diseased artery) coronary artery disease (CAD).